Dose-Escalation Study of PHA-793887 in Patients With Advanced/Metastatic Solid Tumors

PHASE1TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions

Advanced/Metastatic Solid Tumors

Interventions

DRUG

PHA-793887

Escalating doses of PHA-793887 administered weekly by IV infusion for 3 consecutive weeks in 4-week cycles.

Trial Locations (2)

Institut Gustave-Roussy, Villejuif

St. James University Hospital, Leeds